DK0759299T3 - Potensering af serotoninrespons - Google Patents

Potensering af serotoninrespons

Info

Publication number
DK0759299T3
DK0759299T3 DK96305999T DK96305999T DK0759299T3 DK 0759299 T3 DK0759299 T3 DK 0759299T3 DK 96305999 T DK96305999 T DK 96305999T DK 96305999 T DK96305999 T DK 96305999T DK 0759299 T3 DK0759299 T3 DK 0759299T3
Authority
DK
Denmark
Prior art keywords
potentiation
serotonin
serotonin response
response
tryptophan
Prior art date
Application number
DK96305999T
Other languages
Danish (da)
English (en)
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0759299T3 publication Critical patent/DK0759299T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96305999T 1995-08-16 1996-08-16 Potensering af serotoninrespons DK0759299T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US244095P 1995-08-16 1995-08-16

Publications (1)

Publication Number Publication Date
DK0759299T3 true DK0759299T3 (da) 2000-08-07

Family

ID=21700772

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96305999T DK0759299T3 (da) 1995-08-16 1996-08-16 Potensering af serotoninrespons

Country Status (9)

Country Link
EP (1) EP0759299B1 (de)
AT (1) ATE192042T1 (de)
AU (1) AU6776196A (de)
DE (1) DE69607904T2 (de)
DK (1) DK0759299T3 (de)
ES (1) ES2145977T3 (de)
GR (1) GR3034007T3 (de)
PT (1) PT759299E (de)
WO (1) WO1997006792A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
ATE283694T1 (de) * 1998-05-08 2004-12-15 Upjohn Co Neue arzneimittelkombinationen aus reboxetin und pindolol
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
US6046242A (en) * 1998-11-27 2000-04-04 Basf Aktiengesellschaft Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6218395B1 (en) * 1999-08-02 2001-04-17 Conrad Melton Swartz Centrally-acting beta-blockers and serotonin-enhancers for the treatment of anxiety disorders and adjustment disorders with anxiety
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6635675B2 (en) * 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7704527B2 (en) 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
CA2503121A1 (en) 2002-10-25 2004-05-13 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2010132521A1 (en) * 2009-05-13 2010-11-18 Sepracor Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) * 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
NL300886A (de) * 1962-11-23
US3471515A (en) * 1965-02-01 1969-10-07 Sandoz Ag (2-hydroxy-3-substituted aminopropoxy)indoles
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
DE1668055B2 (de) * 1967-03-10 1973-09-06 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung
GB1308191A (en) * 1970-04-06 1973-02-21 Science Union & Cie Thiochroman derivatives and a process for preparing them
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
NL7503310A (nl) * 1975-03-20 1976-09-22 Philips Nv Verbindingen met antidepressieve werking.
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
US4853377A (en) * 1985-10-15 1989-08-01 Pollack Robert L Method and composition for increasing production of serotonin
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten

Also Published As

Publication number Publication date
DE69607904D1 (de) 2000-05-31
ATE192042T1 (de) 2000-05-15
PT759299E (pt) 2000-09-29
EP0759299A1 (de) 1997-02-26
AU6776196A (en) 1997-03-12
EP0759299B1 (de) 2000-04-26
GR3034007T3 (en) 2000-11-30
WO1997006792A1 (en) 1997-02-27
DE69607904T2 (de) 2000-10-05
ES2145977T3 (es) 2000-07-16

Similar Documents

Publication Publication Date Title
DK0759299T3 (da) Potensering af serotoninrespons
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
ATE218825T1 (de) Zahnbürste mit federnden kopfteil
NO980424L (no) Ipratropiumbromid-enantiomer med forlenget virkningstid
NO982807L (no) Nye forbindelser med analgetisk virkning
FI924982A0 (fi) Frystorkat preparat som innehaoller monoklonal motkropp
CA2134038A1 (en) Potentiation of Drug Response
DK0531410T3 (da) (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
DE69605430T2 (de) Chinolin-2-on derivate als serotonin antagonisten
DK0519820T3 (da) Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration
EE9700245A (et) 5-HT tagasihaarde inhibiitori kombinatsioon selektiivse 5-HT1A antagonistiga
NO963984D0 (no) Nye, 1,4-disubstituerte piperidinderivater anvendbare som legemidler som virker på glutamatreseptorer
FI962969A0 (fi) Indolijohdannaisia 5-HT1:n agonisteina
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
NO954287L (no) Anvendelse av indolderivater som 5-HT1 agonister
ES2191942T3 (es) Nueva utilizacion de un antagonista especifico de los receptores 5ht2a.
DE69023332D1 (de) Led-Belichtungskopf.
DE69011732D1 (de) Serotonin-Antagonist.
DK1021442T3 (da) Derivater af 8-azabicyclo[3.2.1] octan-3-methanamin som ligander til D2- og D3-dopaminreceptorerne og 5HT1A- og 5HT2-serotoninreceptorerne
DZ2556A1 (fr) Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant.
FI915717A0 (fi) Fast oral preparat som innehaoller katekolfoerening.
DE69609317D1 (de) Overhead projektor mit vibrationsdämpfung des projektionskopfes
KR910009265A (ko) 마취제의 제조에 있어서의 이미다조피리딘의 사용
DK0987269T3 (da) Salte af optisk aktivt sulfoxidderivat
IT9002106A0 (it) Paraboloide policromatico per proiettore di effetti luminosi associati al ritmo dei suoni.